Amish Patel

Amish Patel is an experienced drug safety physician currently serving as the Associate Director of Drug Safety at Cytokinetics since July 2025. Prior to this role, Amish held the position of Associate Director of Drug Safety and Pharmacovigilance at Biomea Fusion from October 2022 to June 2025, where responsibilities included overseeing safety vendor management and medical assessment of adverse events. Previous roles included Associate Director of Medical Review at Alexion Pharmaceuticals, where Amish managed medical review for clinical trial adverse event reports, and a Drug Safety Physician at Portola Pharmaceuticals, focusing on pharmacovigilance activities for marketed and investigational products. Additional experience spans various safety-related positions at Genentech and Gilead Sciences. Amish holds a BA in Integrative Biology from the University of California, Berkeley and a medical degree from AUC School of Medicine.